Clin2
NCT07399561Possibly a fitNot yet recruiting

Exercise for nerve pain from chemotherapy

Peripheral Neuropathy, Secondary to Drugs or ChemicalsOxaliplatin Induced Peripheral Neuropathy in Cancer PatientsPaclitaxel Induced Neuropathy

Part of Brain & nervous system clinical trials.

This trial tests whether a structured exercise program can reduce or prevent nerve pain and numbness caused by certain chemotherapy drugs. It is for people with colorectal or gynecologic cancer who are about to start treatment with oxaliplatin or paclitaxel.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
140 people
Ages
19 years to 75 years
Study type
Interventional

Who can take part

  • You have colorectal cancer and are about to start oxaliplatin chemotherapy, or you have gynecologic cancer and are about to start paclitaxel chemotherapy.
  • You are able to care for yourself and are up and about more than half of your waking hours (Karnofsky score 70 or higher).
  • You do not already have nerve pain or numbness from other causes.
  • You do not have other serious health problems that would make exercise unsafe.
  • You are not already doing a structured moderate- or high-intensity exercise program similar to the one in this study.
  • You are able to understand and follow the study instructions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06962579Recruiting
Exercise to prevent chemotherapy nerve damage

This study tests whether a personalized exercise program at home can help prevent nerve damage (peripheral neuropathy) caused by certain chemotherapy drugs. It is for people with breast, gynecological, or colon cancer starting a new chemotherapy treatment.

Edegem
NCT07700901Recruiting
Acupuncture and exercise for nerve pain from chemo

This study tests if electroacupuncture (a type of acupuncture with mild electric pulses) combined with exercise can help reduce numbness, tingling, or pain caused by certain chemotherapy drugs. If you have nerve symptoms from taxane or platinum chemo and can walk on your own, this may be a good fit.

Changhua, Changhua
NCT07877558Not yet recruiting
Exercise and gentle nerve stimulation for chemo-related nerve damage

This trial tests a home-based program combining gentle exercise with a small device that stimulates the vagus nerve (a nerve that helps calm the body) to relieve nerve pain, numbness, and tingling in the hands and feet caused by chemotherapy. If you've had these symptoms after platinum or taxane chemotherapy, this may help improve your daily comfort and function.

Hong Kong
NCT04652609Recruiting
Exercise program to prevent nerve damage from chemotherapy

This trial studies an exercise program (PRESIONA) that may help prevent nerve pain or numbness caused by a common type of breast cancer chemotherapy called taxane-based treatment. It targets people with HER2-positive breast cancer who are about to start neoadjuvant chemotherapy.

Granada
NCT07481149Recruiting· Phase 3
Virtual exercise program for chemo nerve damage

This study tests a virtual exercise program to help people with nerve pain or numbness after chemotherapy. It is designed for anyone who finished chemo at least 6 months ago and still has symptoms in their hands or feet.

Toronto, Ontario
NCT07410169Recruiting· Phase 2/Phase 3
Oxygen therapy for chemo-related nerve pain in breast cancer

This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce nerve pain caused by the chemotherapy drug nab-paclitaxel in breast cancer patients. It may help women who have finished chemo and are still dealing with numbness, tingling, or pain in their hands or feet.

Guangzhou, Guangdong

Hear when a new Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.